Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective
<p>Androgen deprivation therapy (ADT), which involves the maximal suppression of circulating testosterone, underpins the treatment approach to metastatic hormone sensitive prostate cancer. Although initial responses are generally favourable, approximately half of cases progress to metastatic c...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2017
|